Pharvaris (PHVS) Current Leases (2021 - 2026)

Pharvaris (PHVS) posted Current Leases of $241537.7 for Q1 2026, up 3.64% on a QoQ basis from $233056.6 in Q4 2025, and up 18.0% year-over-year from $204695.7 in Q1 2025.

Pharvaris (PHVS) Current Leases (2021 - 2026) Analysis & Trends

Pharvaris' Current Leases history runs 6 years deep, the most recent figure standing at $241537.7 for Q1 2026.

  • Quarterly Current Leases rose 18.0% year-over-year to $241537.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $241537.7 (up 18.0% YoY) and the FY2025 annual result came in at $226202.9, down 6.04% from the prior year.
  • Current Leases was $241537.7 for Q1 2026 at Pharvaris, up from $233056.6 in the prior quarter.
  • Across five years, Current Leases topped out at $248405.4 in Q2 2023 and bottomed at $104057.5 in Q2 2024.
  • A 5-year average of $179872.2 and a median of $191198.4 in 2022 frame the typical range for Current Leases.
  • Annual changes were most pronounced in 2023 — Current Leases surged 114.24% — and 2024, when it plunged 58.11%.
  • Pharvaris' Current Leases stood at $191198.4 in 2022, then rose by 9.93% to $210175.2 in 2023, then grew by 13.09% to $237684.5 in 2024, then dropped by 1.95% to $233056.6 in 2025, then gained by 3.64% to $241537.7 in 2026.
  • Business Quant data shows PHVS's Current Leases at $241537.7 in Q1 2026, $233056.6 in Q4 2025, and $160881.9 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 531,233.95
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 20.58 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 720.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 16.61 Mn
10 Pharvaris 2.22 Bn 1.94 Bn - 241,537.71

Historic Data

Download Data
DateValue
Mar 31, 2026 241,537.71
Dec 31, 2025 233,056.64
Sep 30, 2025 160,881.85
Jun 30, 2025 182,861.30
Mar 31, 2025 204,695.66
Dec 31, 2024 237,684.47
Sep 30, 2024 109,205.85
Jun 30, 2024 104,057.49
Mar 31, 2024 130,864.22
Dec 31, 2023 210,175.18
Sep 30, 2023 212,646.35
Jun 30, 2023 248,405.43
Mar 31, 2023 244,850.74
Dec 31, 2022 191,198.44
Sep 30, 2022 113,216.10
Jun 30, 2022 118,200.00
Mar 31, 2022 114,289.89
Dec 31, 2021 113,747.32